Landmark Judgements on Patent Law in India

Explore the most significant landmark judgements on patent law in India. This curated collection covers Supreme Court and High Court decisions on Patent infringement, Patentability, Section 3(d), Compulsory licensing and Pharmaceutical Patents – Essential reading for law Students, Advocates, Researchers and IP Professionals.

FAQs on Landmark Patent Judgements in India

Q1. What is the most landmark patent judgement in India?
A. Novartis AG v. Union of India (2013) is India’s most significant patent case, interpreting Section 3(d) of the Patents Act, 1970.

Q2. What does Section 3(d) of the Patents Act mean?
A. Section 3(d) prevents patent Evergreening by requiring enhanced efficacy for new forms of known substances.

Q3. What was decided in Cipla Ltd. v. F. Hoffmann-La Roche Ltd.?
A. The Delhi High Court addressed patent infringement and public interest in access to life-saving medicines.

Q4. Are Supreme Court patent judgements binding in India?
A. Yes. Supreme Court judgements on patent law are binding on all courts and tribunals across India.

Q5. Where can I study patent case laws for LLM and judiciary exams?
A. PATENEVO provides detailed analysis of landmark patent judgements curated for law students, LLM aspirants and judiciary exam preparation.